Baxter Bros Inc Amgen Inc Transaction History

Baxter Bros Inc

$853 Million
Q3 2025

A detailed history of Baxter Bros Inc transactions in Amgen Inc stock. As of the latest transaction made, Baxter Bros Inc holds 2,196 shares of AMGN stock, worth $649,598. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,196

Previous 2,296 4.36%

Holding current value

$649,598

Previous $641,000 3.43%

% of portfolio

0.07%

Previous 0.08%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$271.18 - $309.22 $27,118 - $30,922	-100 Reduced 4.36%	2,196 $619,000
Q2 2025 Jul 23, 2025	SELL	$262.28 - $309.85 $52,455 - $61,970	-200 Reduced 8.01%	2,296 $641,000
Q1 2025 Apr 09, 2025	SELL	$258.59 - $327.36 $12,929 - $16,368	-50 Reduced 1.96%	2,496 $777,000
Q4 2024 Feb 11, 2025	SELL	$258.78 - $328.31 $10,868 - $13,789	-42 Reduced 1.62%	2,546 $663,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $95,903 - $116,548	-365 Reduced 12.36%	2,588 $808,000
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $8,066 - $9,736	30 Added 1.03%	2,953 $839,000
Q4 2023 May 17, 2024	SELL	$255.7 - $288.46 $7,671 - $8,653	-30 Reduced 1.02%	2,923 $841,000
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $11,506 - $12,980	45 Added 1.56%	2,923 $841,000
Q3 2023 May 17, 2024	SELL	$218.65 - $271.46 $16,398 - $20,359	-75 Reduced 2.54%	2,878 $773,000
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $5,466 - $6,786	25 Added 0.88%	2,878 $773,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1,499 - $1,773	-7 Reduced 0.24%	2,853 $633,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $4,515 - $5,504	-20 Reduced 0.69%	2,860 $691,000
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $8,703 - $11,058	-38 Reduced 1.3%	2,880 $756,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $31,199 - $35,187	-139 Reduced 4.55%	2,918 $658,000
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $4,152 - $4,621	-18 Reduced 0.59%	3,057 $744,000
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $14,252 - $15,767	-65 Reduced 2.07%	3,075 $744,000
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $13,921 - $15,932	-70 Reduced 2.18%	3,140 $706,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $43,515 - $50,983	-205 Reduced 6.0%	3,210 $683,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $20,788 - $23,063	-89 Reduced 2.54%	3,415 $832,000
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $135,587 - $158,004	611 Added 21.12%	3,504 $872,000
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $16,444 - $19,582	76 Added 2.7%	2,893 $665,000
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $129,996 - $144,566	-554 Reduced 16.43%	2,817 $716,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $42,726 - $52,431	-216 Reduced 6.02%	3,371 $795,000
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $22,780 - $30,212	-125 Reduced 3.37%	3,587 $727,000
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $321,467 - $413,196	1,699 Added 84.4%	3,712 $895,000
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $321,278 - $412,953	-1,698 Reduced 45.76%	2,013 $321,000
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $27,857 - $33,379	-160 Reduced 4.13%	3,711 $718,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $12,669 - $14,851	-76 Reduced 1.93%	3,871 $713,000
Q1 2019 Apr 22, 2019	SELL	$180.87 - $203.88 $7,053 - $7,951	-39 Reduced 0.98%	3,947 $750,000
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $535 - $624	3 Added 0.08%	3,986 $776,000
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $13,896 - $15,666	75 Added 1.92%	3,983 $826,000
Q2 2018 Jul 17, 2018	BUY	$166.05 - $186.51 $59,944 - $67,330	361 Added 10.18%	3,908 $721,000
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $22,873 - $26,730	-135 Reduced 3.67%	3,547 $605,000
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $34,264 - $38,283	203 Added 5.84%	3,682 $640,000
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $582,001 - $664,489	3,479	3,479 $649,000

Others Institutions Holding AMGN

# of Institutions

3,281

Shares Held

441M

Call Options Held

6.14M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account